AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
Filters
[Clear]
- Price Sensitive: Yes
| SCL | Schrole enters into strategic alliance with ISS | PRICE SENSITIVE | 05/04/18 | |
| SCL | Trading Halt | PRICE SENSITIVE | 03/04/18 | |
| SCL | Schrole Teacher Placement Research Program with ECU | PRICE SENSITIVE | 27/03/18 | |
| SCL | Appedix 4E Preliminary Final Report | PRICE SENSITIVE | 28/02/18 | |
| SCL | Schrole Commercial Partnership with Sentral | PRICE SENSITIVE | 21/11/17 | |
| SCL Schrole enters into strategic alliance with ISS | |||
| 05/04/18 | PRICE SENSITIVE | ||
| SCL Trading Halt | |||
| 03/04/18 | PRICE SENSITIVE | ||
| SCL Schrole Teacher Placement Research Program with ECU | |||
| 27/03/18 | PRICE SENSITIVE | ||
| SCL Appedix 4E Preliminary Final Report | |||
| 28/02/18 | PRICE SENSITIVE | ||
| SCL Schrole Commercial Partnership with Sentral | |||
| 21/11/17 | PRICE SENSITIVE | ||
